Wells Fargo’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ARMP
MAM
DIG
Wells Fargo's ARMP Position: Q2 2026 in Review
Wells Fargo increased its Armata Pharmaceuticals (ARMP) stake by 1,081,800% in Q2 2026, buying an estimated $99.2K and bringing the position to 10,819 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5625.
Wells Fargo first reported a position in ARMP in Q1 2020 and has held it in 26 quarters since. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.
- Wells Fargo held 10,819 shares of Armata Pharmaceuticals worth $70.1K as of Q2 2026.
- Wells Fargo bought 10,818 Armata Pharmaceuticals shares in Q2 2026, an estimated $99.2K.
- Armata Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5625 holding.
- Wells Fargo first reported a position in Armata Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
- 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.